You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Investigational Drug Information for Oxfendazole


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for Oxfendazole?

Oxfendazole is an investigational drug.

There have been 7 clinical trials for Oxfendazole. The most recent clinical trial was a Phase 1 trial, which was initiated on November 1st 2019.

The most common disease conditions in clinical trials are Trichuriasis, Helminthiasis, and Taeniasis. The leading clinical trial sponsors are National Institute of Allergy and Infectious Diseases (NIAID), Universidad Peruana Cayetano Heredia, and Johns Hopkins Bloomberg School of Public Health.

There are three hundred and ten US patents protecting this investigational drug and five international patents.

Recent Clinical Trials for Oxfendazole
TitleSponsorPhase
Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in AdultsUniversidad Peruana Cayetano Heredia, Lima, PeruPhase 2
Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in AdultsOxfendazole Development GroupPhase 2
PK, Safety and Tolerability of Single and Multiple Doses of Oxfendazole TabletsDrugs for Neglected DiseasesPhase 1

See all Oxfendazole clinical trials

Clinical Trial Summary for Oxfendazole

Top disease conditions for Oxfendazole
Top clinical trial sponsors for Oxfendazole

See all Oxfendazole clinical trials

US Patents for Oxfendazole

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
oxfendazole ⤷  Try a Trial Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof The Regents of the University of California (Oakland, CA) ⤷  Try a Trial
oxfendazole ⤷  Try a Trial Drug device configured for wireless communication Pop Test Abuse Deterrent Technology, LLC (Cliffside Park, NJ) ⤷  Try a Trial
oxfendazole ⤷  Try a Trial Fast dissolving pharmaceutical composition Ferring B.V. (Hoofddorp, NL) ⤷  Try a Trial
oxfendazole ⤷  Try a Trial Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same Platform Brightworks Two, Ltd. (Houston, TX) ⤷  Try a Trial
oxfendazole ⤷  Try a Trial Six-membered C--N-bonded aryl sulphide and aryl sulphoxide derivatives as pesticides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (Monheim am Rhein, DE) ⤷  Try a Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Oxfendazole

Drugname Country Document Number Estimated Expiration Related US Patent
oxfendazole European Patent Office EP2981556 2033-04-02 ⤷  Try a Trial
oxfendazole World Intellectual Property Organization (WIPO) WO2014165513 2033-04-02 ⤷  Try a Trial
oxfendazole Australia AU2015286634 2034-07-11 ⤷  Try a Trial
oxfendazole Brazil BR112017000398 2034-07-11 ⤷  Try a Trial
oxfendazole China CN106659720 2034-07-11 ⤷  Try a Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.